Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.330
+0.080 (6.40%)
At close: Mar 9, 2026, 4:00 PM EDT
1.271
-0.059 (-4.41%)
After-hours: Mar 9, 2026, 7:53 PM EDT
Dermata Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3 | 3 | 2 | 5 | 14 | - | |
| Market Cap Growth | -52.61% | 27.62% | -56.38% | -65.85% | - | - | |
| Enterprise Value | -1 | -3 | -4 | -3 | 2 | - | |
| Last Close Price | 1.33 | 13.50 | 91.50 | 981.60 | 4176.00 | - | |
| PB Ratio | 0.28 | 1.77 | 0.34 | 0.82 | 1.43 | - | |
| P/TBV Ratio | 0.80 | 1.77 | 0.34 | 0.82 | 1.43 | - | |
| Debt / Equity Ratio | - | - | - | - | - | -1.12 | |
| Net Debt / Equity Ratio | -1.18 | -2.02 | -1.17 | -1.04 | -1.07 | -0.95 | |
| Net Debt / EBITDA Ratio | - | - | - | - | 1.37 | -0.95 | |
| Quick Ratio | 4.20 | 1.60 | 4.58 | 6.78 | 7.12 | 0.14 | |
| Current Ratio | 4.56 | 1.79 | 4.91 | 7.53 | 7.66 | 0.16 | |
| Return on Equity (ROE) | -203.36% | -310.44% | -125.96% | -119.18% | -228.09% | - | |
| Return on Assets (ROA) | -96.45% | -135.86% | -67.36% | -65.13% | -80.31% | -148.47% | |
| Return on Capital Employed (ROCE) | -229.10% | -801.60% | -126.50% | -160.70% | -77.70% | 99.80% | |
| Earnings Yield | -278.73% | -446.00% | -361.07% | -194.19% | -54.53% | - | |
| Buyback Yield / Dilution | -871.92% | -684.78% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.